Fundraising Fox

Yumanity Therapeutics

Boston, US · Delaware corporation · 1 known investors

Healthtech

Founders & leadership

NA
N. Anthony ColesFounder
RP
Richard PetersExecutive
PM
Paulash MohsenExecutive
BR
Brigitte RobertsonExecutive
RA
Richard A. HeymanNamed on SEC filing
JW
Jeffery W. KellyNamed on SEC filing
CB
Cecil B. PickettNamed on SEC filing
LZ
Lynne ZydowskyNamed on SEC filing

Board

PL
Patricia L. AllenBoard director
DA
David ArkowitzBoard director
KC
Kim C. DrapkinBoard director

Investors · 1

Pfizer Venture Investments$5M – $20M

Reported raises · per SEC filings

Form D private placements

$78.1M disclosed across 4 of 5 rounds · 2014–2023

▶$2.9MofferedOct 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn P. IadonatoExecutive Officer, Director
  • Pauline KennyExecutive Officer
  • Craig W. PhilipsExecutive Officer
  • Richard PetersDirector
  • Marion R. FooteDirector
  • Thierry GuillaudeuxExecutive Officer
  • Raymond BartoszekDirector
  • Keith A. BakerExecutive Officer
  • Kimberlee C. DrapkinDirector
  • Scott J. DyllaDirector
  • David ArkowitzDirector
Offering amount
$2.9M
Sales commissions
$210K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedDec 2022 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Raymond BartoszekDirector
  • David ArkowitzDirector
  • Keith A. BakerExecutive Officer
  • Richard PetersDirector
  • Marion R. FooteDirector
  • Shawn IadonatoExecutive Officer, Director
  • Craig W. PhilipsExecutive Officer
Offering amount
$30M
Amount sold
$7.5M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$33.6MraisedJan 2021 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard PetersExecutive Officer, Director
  • N. Anthony ColesExecutive Officer, Director
  • Paulash MohsenExecutive Officer
  • Brigitte RobertsonExecutive Officer
  • Patricia L. AllenDirector
  • David ArkowitzDirector
  • Kim C. DrapkinDirector
  • Richard A. HeymanDirector
  • Jeffery W. KellyDirector
  • Cecil B. PickettDirector
  • Lynne ZydowskyDirector
Offering amount
$33.6M
Amount sold
$33.6M
Sales commissions
$1.7M
Placement agents
Jefferies LLC
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22MraisedSep 2015 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFERY W. KELLYDirector
  • M. JAMES BARRETTDirector
  • CONOR WALSHEDirector
  • CHRISTOPHER K. MIRABELLIDirector
  • IRENA MELNIKOVAPromoter
  • CHRISTOPHER T. WALSHDirector
  • MEENU CHHABRAExecutive Officer, Director
  • NADIA USTARIZExecutive Officer
  • JANET SMARTExecutive Officer
  • STEPHEN KNIGHTDirector
  • HENRY B. SKINNERDirector
  • BERNARD DAVITIANDirector
Offering amount
$28M
Amount sold
$22M
Sales commissions
$720K
Proceeds to insiders
$720K
Placement agents
Irena Melnikova
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedSep 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MEENU CHHABRAExecutive Officer, Director
  • BERNARD DAVITIANDirector
  • NADIA USTARIZExecutive Officer
  • JANET SMARTExecutive Officer
  • STEPHEN KNIGHTDirector
  • M. JAMES BARRETTDirector
  • CHRISTOPHER MIRABELLIDirector
  • CONOR WALSHEDirector
  • CHRISTOPHER WALSHDirector
  • JEFFERY KELLYDirector
  • HENRY SKINNERDirector
Offering amount
$15M
Amount sold
$15M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Yumanity Therapeutics?
Yumanity Therapeutics was founded by N. Anthony Coles.
Who are Yumanity Therapeutics's investors?
Yumanity Therapeutics's investors include Pfizer Venture Investments.
How much funding has Yumanity Therapeutics raised?
Yumanity Therapeutics has disclosed $78.1M raised across 4 of its 5 known rounds.
Where is Yumanity Therapeutics headquartered?
Yumanity Therapeutics is headquartered in Boston, US.